Abstract
Respiratory infection is the most frequent and characteristic infectious comorbidity in patients with chronic obstructive pulmonary disease (COPD) and can lead to two clinical scenarios. The first and most common is exacerbation, although not all exacerbations are caused by infections, which account for 50-70% of these processes. The second scenario is pneumonia, since COPD is the most frequent comorbidity associated with the development of pneumonia. Of the infectious agents causing exacerbations, 50-60% of cases correspond to bacteria, which are the most widely studied microorganisms and whose role is becoming increasingly notorious. Among bacteria, a greater number of Pseudomonas aeruginosa and more aggressive microorganisms are being isolated in exacerbations. A second cause of infectious exacerbations are viruses, which seem to play an important role in these processes, although less so than bacteria. Viral infections seem to predispose many patients to a subsequent bacterial infection. Community-acquired pneumonia (CAP) is highly common in patients with COPD and between 25 and 50% of patients hospitalized with this diagnosis have COPD. Nevertheless, COPD has not been considered as a risk factor for poor outcome in patient...Continue Reading
References
Mar 13, 1975·The New England Journal of Medicine·I Tager, F E Speizer
Jul 1, 1989·Reviews of Infectious Diseases·T J MarrieL Yates
Oct 1, 1995·American Journal of Respiratory and Critical Care Medicine·E MonsóV Ausina
Mar 1, 1994·Chest·S R Mohnssen
Nov 1, 1996·American Journal of Respiratory and Critical Care Medicine·A TorresJ Serra
Jan 23, 1997·The New England Journal of Medicine·M J FineW N Kapoor
Jul 3, 1999·American Journal of Respiratory and Critical Care Medicine·N MogulkocN Colpan
Nov 24, 2001·American Journal of Respiratory and Critical Care Medicine·T SeemungalJ A Wedzicha
Apr 20, 2002·Current Opinion in Infectious Diseases·Peter Ball
Nov 2, 2004·Thorax·R MenéndezUNKNOWN Neumofail Group
Aug 23, 2005·Proceedings of the American Thoracic Society·Sanjay Sethi
Aug 23, 2005·Proceedings of the American Thoracic Society·Peter M A Calverley
Apr 14, 2006·The European Respiratory Journal·M I RestrepoA Anzueto
Feb 10, 2007·American Journal of Respiratory and Critical Care Medicine·Daniel DroemannKlaus Dalhoff
Feb 23, 2007·The New England Journal of Medicine·Peter M A CalverleyUNKNOWN TORCH investigators
Apr 27, 2007·The European Respiratory Journal·B M W DiederenR Hendrix
Dec 13, 2007·Proceedings of the American Thoracic Society·Annemarie SykesSebastian L Johnston
Feb 28, 2008·Current Opinion in Pulmonary Medicine·Saad Nseir, Florence Ader
Nov 29, 2008·The New England Journal of Medicine·Sanjay Sethi, Timothy F Murphy